A new medical food product has been developed to improve the memory of individuals who suffer from a mild form of Alzheimer's disease.
A second clinical trial presented at the 4th International Conference on Clinical Trials in Alzheimer's Disease in San Diego revealed that daily intake of Souvenaid may improve memory.
"I'm encouraged by the results of this second trial, but we need to do more analyses and further studies to fully understand the findings," said Philip Scheltens, Director of the Alzheimer Center at the VU University Medical Center in Amsterdam. "These positive results give me the energy to go forward."
Souvenaid contains a combination of nutrients put together by scientists that are designed to stimulate synapses in the brain, the absence of which are thought to cause Alzheimer's.
Subjects of the study took Souvenaid daily for 24 weeks, and the majority showed improvement on standardized memory tests.
According to the Alzheimer's Association, the disease is the sixth leading cause of death in the United States, making early preparation for the future through investing in life insurance a wise choice.